Osteostimulation

Jump to navigation Jump to search

WikiDoc Resources for Osteostimulation

Articles

Most recent articles on Osteostimulation

Most cited articles on Osteostimulation

Review articles on Osteostimulation

Articles on Osteostimulation in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Osteostimulation

Images of Osteostimulation

Photos of Osteostimulation

Podcasts & MP3s on Osteostimulation

Videos on Osteostimulation

Evidence Based Medicine

Cochrane Collaboration on Osteostimulation

Bandolier on Osteostimulation

TRIP on Osteostimulation

Clinical Trials

Ongoing Trials on Osteostimulation at Clinical Trials.gov

Trial results on Osteostimulation

Clinical Trials on Osteostimulation at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Osteostimulation

NICE Guidance on Osteostimulation

NHS PRODIGY Guidance

FDA on Osteostimulation

CDC on Osteostimulation

Books

Books on Osteostimulation

News

Osteostimulation in the news

Be alerted to news on Osteostimulation

News trends on Osteostimulation

Commentary

Blogs on Osteostimulation

Definitions

Definitions of Osteostimulation

Patient Resources / Community

Patient resources on Osteostimulation

Discussion groups on Osteostimulation

Patient Handouts on Osteostimulation

Directions to Hospitals Treating Osteostimulation

Risk calculators and risk factors for Osteostimulation

Healthcare Provider Resources

Symptoms of Osteostimulation

Causes & Risk Factors for Osteostimulation

Diagnostic studies for Osteostimulation

Treatment of Osteostimulation

Continuing Medical Education (CME)

CME Programs on Osteostimulation

International

Osteostimulation en Espanol

Osteostimulation en Francais

Business

Osteostimulation in the Marketplace

Patents on Osteostimulation

Experimental / Informatics

List of terms related to Osteostimulation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Osteostimulation is a technique attempted for improving healing of bone injuries or defects. It has not however been found to be significantly effective in increasing bone healing.[1]

It was believed to work through the active stimulation of osteoblast proliferation and differentiation as evidenced by increased levels of DNA synthesis and of the osteoblast markers osteocalcin and alkaline phosphatase. Through an ionic exchange, Bioglass first acts as a scaffolding around and through which new bone forms. In vivo studies have demonstrated that the osteostimulative properties result in stimulation and acceleration of new bone formation in an osseous defect. (FDA 510(k) clearance, February 2006 for PerioGlas).

File:Ostim1.jpg

Osseous defects, whether from trauma or surgical intervention, all follow a similar healing pattern. Within minutes of defect formation, platelets collect at the site of the injury and adhere to the exposed collagen fibers. The release of the platelet contents stimulates additional platelet aggregation and initiates clot formation.1 This release also has a chemotactic effect and attracts various white blood cells (leukocytes) to the damaged tissues and an acute inflammatory response is initiated. Neutrophils and other leukocytes begin removing any bacteria, foreign material, and dead tissue via a process known as phagocytosis.1The inflammatory response and other antigens in the wound also attract lymphocytes. These immune cells release cytokines, such as IL-1 and TNF-α,which can have multiple actions on further physiologic responses. For example, IL-1 amplifies the immune response by inducing the proliferation of T-cells, increases the phagocytic abilities of monocytes and macrophages, and induces the proliferation of fibroblasts. The disruption of the vascular supply, and the subsequent cellular reactions during the inflammatory and immune reactions, result in multiple changes in the local environment, including decreases in pH, oxygen content and the ionic concentrations for calcium, phosphorus, potassium and sodium. If these conditions persist, a chronic inflammatory response may set in, resulting in extensive tissue destruction.2 With respect to implant materials, chronic inflammation and foreign body reactions are associated with the development of a fibrous capsule around the implant. The goal of a graft material is to aid in tissue healing.

By moderating pH and ionic concentration changes3, Bioglass may reduce the release or attraction of the immune cells, decreasing the time course and extent of the inflammatory response. Indirect evidence for this has been seen in recent research showing decreased TNF-α4 and elastase5 levels in the presence of Bioglass when compared to controls.

Osteostimulation and pH

While normal tissue pH is 7.4-7.6, the inflammatory response can reduce local pH to 5.5 or lower due to the damaged vasculature and the release of various enzymes during phagocytosis.2 This acidic pH is itself damaging to the surrounding tissues and, by stimulating new inflammatory reactions, acts to prolong the healing process.1 Conversely, in vitro testing of Bioglass has shown an increase in local pH around the graft material.3Clinical evaluations in oral and periodontal defects have demonstrated a reduced level of tissue inflammation over defects grafted with Bioglass.6 This may be attributed in part to the partial neutralization of the acidic pH changes normally seen during the inflammatory process.

File:Ostim2a.jpg

Osteostimulation and hemostasis

Bioglass has been shown to be hemostatic, decreasing clotting time in lab tests by 25% when compared to controls.7 While the actual origin of this effect has not yet being ascertained, two potential hypothesis are the development of a positive surface charge that forms on the Bioglass after implantation and the release of calcium ions during material dissolution. A positive surface charge has been shown to encourage clotting in a number of models. In addition, calcium ions are required during several steps in the both the intrinsic and extrinsic clotting pathways, and are also involved in maturation of the fibrin network developed during clotting.1 The continued physical presence of the Bioglass particles and its prolonged release of calcium ions may act to stabilize the formed clot or callus to encourage more rapid site vascularization and provide an active scaffold for tissue repair.

Stimulation and recruitment of osteoblasts

The presence and recruitment of osteoblasts, the “bone-forming” cells, are required for bone healing. Within 24 hours of implantation, in vitro testing has shown that the calcium and phosphorus ions released from the Bioglass precipitate back onto the particles as a calcium phosphate surface layer.3 This layer is similar to normal bone mineral, creating a surface that is more favorable to osteoblast attachment than other synthetic materials.8 Cultures with human primary osteoblasts have shown that bioactive glass stimulates the proliferation and differentiation of osteoblasts9, with calcified bone nodule formation on the material surfaces being observed as early as six days. Additionally, these same investigators also have demonstrated that the ionic species released during the dissolution of Bioglass have a similar effect by increasing osteoblast proliferation.10 Bioglass particles therefore form a three-dimensional porous scaffold with surfaces that stimulate osteoblast proliferation and attachment and bone formation.

References

  1. Mollon B, da Silva V, Busse JW, Einhorn TA, Bhandari M (2008). "Electrical stimulation for long-bone fracture-healing: a meta-analysis of randomized controlled trials". J Bone Joint Surg Am. 90 (11): 2322–30. doi:10.2106/JBJS.H.00111. PMID 18978400. Unknown parameter |month= ignored (help)

Template:WH Template:WS